DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Smith M, Parker C, Saad F. et al
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.
The Lancet Oncology 2019;
20: 408-419 . doi:10.1016/S1470-2045(18)30860-X
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.